differentiated soft tissue sarcomas according to malignancy grade and predicted MDM2-Gene amplification, respectively, achieving AUCs of 0.922 and 0.95, with high sensitivity and specificity values (33, 34). The gene discussed is MDM2; the disease is soft tissue sarcoma.